Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Non-alcoholic Fatty Liver Disease: early-phase trial registry
19 of 58 indexed Non-alcoholic Fatty Liver Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #244 of 28,707 conditions by registered trial count.
58 US clinical trials · 19 currently recruiting · #244 of 28,707 conditions by registered trial count
Non-alcoholic Fatty Liver Disease: 58 US clinical trials tracked, 19 recruiting.
Non-alcoholic Fatty Liver Disease is the subject of 58 registered US clinical trials on ClinicalTrials.gov, 19 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is Pfizer, running 3 of these trials.
Enrollment posture brief
Registry condition non-alcoholic-fatty-liver-disease
OPEN 19 | RECR 33% | LATE 7 | EARLY 22 | RANK #244 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Diabetes Mellitus, Type 1 (33% recruiting · 119 trials)
Non-alcoholic Fatty Liver Disease lists 19 open slots (33% of 58 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Non-alcoholic Fatty Liver Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Non-alcoholic Fatty Liver Disease is recruiting below its size-band peers.
19 of 58 indexed trials (32.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Non-alcoholic Fatty Liver Disease trials is spread across many organizations.
Pfizer accounts for 3 of 58 trials (5.2%). 46 distinct sponsors appear on at least one study for this condition label.
-
Most Non-alcoholic Fatty Liver Disease trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 58 trials that report a genuine target (sentinel values excluded). 39 of those (67.2%) plan for fewer than 100 participants.
-
Non-alcoholic Fatty Liver Disease research is mostly interventional.
48 interventional and 10 observational studies make up this index (82.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
58 total, page 2 of 2
Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents
University of Wisconsin, Madison
NCT02116192
Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease
The University of Texas Health Science Center, Houston
NCT05200585
Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease
Virginia Commonwealth University
NCT02132780
The Effect of an RBAC Supplement (BRM4) on NAFLD
University of Miami
NCT02568787
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
Indiana University
NCT00586313
Iron Depletion Therapy for Type 2 DM and NAFLD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00230087
Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes
University of Massachusetts, Worcester
NCT02132442
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study
Columbia University
NCT01285362
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 17 |
| Phase 3 | 4 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Non-alcoholic Fatty Liver Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Non-alcoholic Fatty Liver Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Non-alcoholic Fatty Liver Disease page
58 registered trials, 19 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 19 Non-alcoholic Fatty Liver Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Pfizer sponsors the most Non-alcoholic Fatty Liver Disease trials on record, review their full trial history before evaluating a specific study. See Pfizer's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Non-alcoholic Fatty Liver Disease condition card totals 58 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.